Trends in Antiviral Drug Development

Edited by Michael J. Sofia Edited by Zhengqiang Wang Series edited by János Fischer Series edited by Christian Klein Series edited by Wayne E. Childers Series edited by David P. Rotella

Image coming soon

Extent: 528 pages

Publisher: Wiley-VCH

Series: Trends in Drug Discovery

Series volume number: 3

Language: English

Hardback (Published)

(June 2025)

ISBN: 9783527353019

6.69 x 9.61 inches

Price: $212.00

On back order

Add to cart -
back order

Trends and challenges in one of the most active areas of contemporary drug development – presented by industry professionals with a track record of discovering new drugs and treatments.

Preface
Introduction: Successes and Challenges in Antiviral Drug Development

Part I: Human Herpes Viruses
Chapter 1: Letermovir
Chapter 2: Pritelivir

Part II: Immunodeficiency Virus
Chapter 3: Dolutegravir
Chapter 4: Islatravir (EFdA)

Part III: Hepatitis Viruses
Chapter 5: Imdusiran
Chapter 6: ARO-HBV/JNJ-3989
Chapter 7: Sofosbuvir
Chapter 8: Lidipasvir and Valpatasvir

Part IV: Respiratory Viruses
Chapter 9: Presatovir
Chapter 10: Remdesivir
Chapter 11: Ensitrelvir
Chapter 12: VV-116
Chapter 13: Molnupiravir

Part V: Tropical Disease Viruses
Chapter 14: Mosnodenvir

Part VI: Orthopoxvirus
Chapter 15: Brincidofovir

 

  • Edited by Michael J. Sofia
  • Edited by Zhengqiang Wang
  • Series edited by János Fischer
  • Series edited by Christian Klein
  • Series edited by Wayne E. Childers
  • Series edited by David P. Rotella

Other Titles in this Series

Book cover: Trends in Drug Discovery in Diabetes and Obesity Trends in Drug Discovery in Diabetes and Obesity

Volume 4

Edited by Lars Linderoth Edited by Søren Østergaard Series edited by János Fischer Series edited…